HEPATITIS B
Clinical trials for HEPATITIS B explained in plain language.
Never miss a new study
Get alerted when new HEPATITIS B trials appear
Sign up with your email to follow new studies for HEPATITIS B, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental hepatitis b drug shows early promise in small trial
Disease control TerminatedThis early-stage study tested a new drug called ARC-521 in 47 people, including healthy volunteers and patients with chronic hepatitis B. The goal was to check safety and how the body processes the drug. The trial was stopped early, so results are limited.
Matched conditions: HEPATITIS B
Phase: PHASE1 • Sponsor: Arrowhead Pharmaceuticals • Aim: Disease control
Last updated May 17, 2026 03:08 UTC
-
Hepatitis b drug trial halted midway
Disease control TerminatedThis study tested an experimental drug called ARC-520 in 79 adults with chronic hepatitis B. Some participants received ARC-520 alone, while others got it with standard treatments like entecavir or tenofovir. The goal was to see if ARC-520 could lower hepatitis B surface antigen …
Matched conditions: HEPATITIS B
Phase: PHASE2 • Sponsor: Arrowhead Pharmaceuticals • Aim: Disease control
Last updated May 15, 2026 11:55 UTC
-
Hepatitis b drug study halted early – what we know
Disease control TerminatedThis early-stage study tested a new drug called GSK3965193, alone or with another drug (bepirovirsen), in healthy volunteers and people with chronic hepatitis B. The goal was to check safety and whether the drug could lower hepatitis B virus levels. The study was terminated early…
Matched conditions: HEPATITIS B
Phase: PHASE1, PHASE2 • Sponsor: GlaxoSmithKline • Aim: Disease control
Last updated May 15, 2026 11:53 UTC
-
Hepatitis b drug trial halted: ARC-520 shows promise but study ends early
Disease control TerminatedThis study tested a new drug called ARC-520, given with standard antiviral pills, to see if it could lower hepatitis B virus levels in people with chronic infection. The trial included 58 adults who had been on antiviral treatment for at least 2 months. The study was stopped earl…
Matched conditions: HEPATITIS B
Phase: PHASE2 • Sponsor: Arrowhead Pharmaceuticals • Aim: Disease control
Last updated May 13, 2026 15:58 UTC
-
Hepatitis b drug combo shows promise but study halted early
Disease control TerminatedThis study looked at adding an experimental drug called ARC-520 to standard hepatitis B treatments (entecavir or tenofovir) in 12 people with chronic hepatitis B. Participants received 9 doses of ARC-520 over 36 weeks. The goal was to see if the combination could reduce a key vir…
Matched conditions: HEPATITIS B
Phase: PHASE2 • Sponsor: Arrowhead Pharmaceuticals • Aim: Disease control
Last updated May 11, 2026 20:47 UTC
-
Experimental hepatitis b drug shows promise in lowering virus levels
Disease control TerminatedThis study tested an experimental drug called ARC-520 in 32 adults with chronic hepatitis B who were already taking standard antiviral medications. Participants received either ARC-520 or a placebo added to their usual treatment. The goal was to see if ARC-520 could further reduc…
Matched conditions: HEPATITIS B
Phase: PHASE2 • Sponsor: Arrowhead Pharmaceuticals • Aim: Disease control
Last updated May 08, 2026 12:03 UTC
-
Researchers track hepatitis b patients to learn how treatments work in real life
Knowledge-focused TerminatedThis study looked at over 1,700 adults with chronic hepatitis B in the US and Canada to understand how the disease progresses and how treatments are used in routine care. Researchers collected data from medical records, not by giving any new treatment. The goal was to learn more …
Matched conditions: HEPATITIS B
Sponsor: Target PharmaSolutions, Inc. • Aim: Knowledge-focused
Last updated May 12, 2026 13:41 UTC
-
Scientists probe immune System's memory to build better vaccines
Knowledge-focused TerminatedThis study aimed to understand how the body's immune memory cells respond to vaccine booster shots. Researchers gave the standard hepatitis B vaccine to healthy volunteers and analyzed cells from their lymph nodes. The goal was to learn the basic rules of how immune memory works,…
Matched conditions: HEPATITIS B
Phase: PHASE4 • Sponsor: Rockefeller University • Aim: Knowledge-focused
Last updated Apr 20, 2026 16:17 UTC